Literature DB >> 28125451

Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma in an Adult Population Without Radiation Exposure.

Raja R Seethala1, Simion I Chiosea, Cheng Z Liu, Marina Nikiforova, Yuri E Nikiforov.   

Abstract

The ETV6-NTRK3 translocation characterizes a subset of radiation associated and pediatric papillary thyroid carcinomas (PTCs). We now describe the clinicopathologic features of ETV6-NTRK3 translocated PTC in an adult population without radiation exposure. Twelve cases were identified by next-generation sequencing (ThyroSeq version 2). The mean patient age was 37 years with a female predilection (10:2). Preoperative fine needle aspiration was performed on 6 patients of which 4 were classified as "malignant," whereas 2 were classified as "follicular lesion of undetermined significance." One third (4/12) of patients demonstrated extrathyroidal extension and one half of patients (5/10) demonstrated lymph node metastases. One patient presented with brain metastasis. Tumors typically (8/12) demonstrated an admixture of follicular and papillary patterns and were usually infiltrative and multinodular (6/12 cases). Tumors often showed clear cell or oncocytic foci and demonstrated overt nuclear features of PTC, though characteristically, interspersed bland areas were common, even in metastases. Cytoplasmic vacuolization resembling that of mammary analog secretory carcinoma was also common but focal. TTF-1 was positive and S100 was negative in all tested cases confirming a thyroid phenotype. Unique morphologies included glomeruloid follicles, reverse polarization of nuclei. Survey of the TCGA datasets revealed similar findings. Thus, ETV6-NTRK3 translocated PTC are locoregionally aggressive and can metastasize distantly. They are characterized by mixture of papillary and follicular architecture and may show cytoplasmic vacuolization akin to other ETV6 translocated carcinomas. Although nuclear features are typically overt, interspersed bland regions may cause diagnostic difficulty in metastatic sites, and may explain discordance on fine needle aspiration.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28125451      PMCID: PMC5384267          DOI: 10.1097/PAS.0000000000000814

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  30 in total

1.  TCGA finds thyroid cancer drivers, subtypes.

Authors: 
Journal:  Cancer Discov       Date:  2014-11-07       Impact factor: 39.397

Review 2.  Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008.

Authors:  Nan Li; Xianglin L Du; Lorraine R Reitzel; Li Xu; Erich M Sturgis
Journal:  Thyroid       Date:  2013-01       Impact factor: 6.568

3.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

4.  Risk stratification of follicular variant of papillary thyroid carcinoma.

Authors:  Marina Vivero; Stefan Kraft; Justine A Barletta
Journal:  Thyroid       Date:  2013-03       Impact factor: 6.568

5.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

6.  Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior.

Authors:  Sofia Asioli; Lori A Erickson; Alberto Righi; Ricardo V Lloyd
Journal:  Hum Pathol       Date:  2012-10-01       Impact factor: 3.466

7.  Molecular Characterization of Sporadic Pediatric Thyroid Carcinoma with the DNA/RNA ThyroSeq v2 Next-Generation Sequencing Assay.

Authors:  Jennifer L Picarsic; Melissa A Buryk; John Ozolek; Sarangarajan Ranganathan; Sara E Monaco; Jeffrey P Simons; Selma F Witchel; Nursen Gurtunca; Judith Joyce; Shan Zhong; Marina N Nikiforova; Yuri E Nikiforov
Journal:  Pediatr Dev Pathol       Date:  2015-09-14

8.  Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.

Authors:  Yuri E Nikiforov; Sally E Carty; Simon I Chiosea; Christopher Coyne; Umamaheswar Duvvuri; Robert L Ferris; William E Gooding; Steven P Hodak; Shane O LeBeau; N Paul Ohori; Raja R Seethala; Mitchell E Tublin; Linwah Yip; Marina N Nikiforova
Journal:  Cancer       Date:  2014-09-10       Impact factor: 6.860

9.  Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion.

Authors:  Snjezana Dogan; Lu Wang; Ryan N Ptashkin; Robert R Dawson; Jatin P Shah; Eric J Sherman; R Michael Tuttle; James A Fagin; David S Klimstra; Nora Katabi; Ronald A Ghossein
Journal:  Mod Pathol       Date:  2016-06-10       Impact factor: 7.842

10.  What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).

Authors:  A Drilon; G Li; S Dogan; M Gounder; R Shen; M Arcila; L Wang; D M Hyman; J Hechtman; G Wei; N R Cam; J Christiansen; D Luo; E C Maneval; T Bauer; M Patel; S V Liu; S H I Ou; A Farago; A Shaw; R F Shoemaker; J Lim; Z Hornby; P Multani; M Ladanyi; M Berger; N Katabi; R Ghossein; A L Ho
Journal:  Ann Oncol       Date:  2016-02-15       Impact factor: 32.976

View more
  11 in total

1.  Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.

Authors:  Diana Bell; Renata Ferrarotto; Li Liang; Ryan P Goepfert; Jie Li; Jing Ning; Russell Broaddus; Randal S Weber; Adel K El-Naggar
Journal:  Virchows Arch       Date:  2019-08-19       Impact factor: 4.064

2.  Cytomorphologic features of NTRK-rearranged thyroid carcinoma.

Authors:  Kartik Viswanathan; Ying-Hsia Chu; William C Faquin; Peter M Sadow
Journal:  Cancer Cytopathol       Date:  2020-10-19       Impact factor: 5.284

Review 3.  Salivary-Like Tumors of the Thyroid: A Comprehensive Review of Three Rare Carcinomas.

Authors:  Meagan Chambers; Vânia Nosé; Peter M Sadow; Laura J Tafe; Darcy A Kerr
Journal:  Head Neck Pathol       Date:  2020-06-19

4.  Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.

Authors:  Alanna J Church; Monica L Calicchio; Valentina Nardi; Alena Skalova; Andre Pinto; Deborah A Dillon; Carmen R Gomez-Fernandez; Namitha Manoj; Josh D Haimes; Joshua A Stahl; Filemon S Dela Cruz; Sarah Tannenbaum-Dvir; Julia L Glade-Bender; Andrew L Kung; Steven G DuBois; Harry P Kozakewich; Katherine A Janeway; Antonio R Perez-Atayde; Marian H Harris
Journal:  Mod Pathol       Date:  2017-11-03       Impact factor: 7.842

Review 5.  New Insights in the Cytogenetic Practice: Karyotypic Chaos, Non-Clonal Chromosomal Alterations and Chromosomal Instability in Human Cancer and Therapy Response.

Authors:  Nelson Rangel; Maribel Forero-Castro; Milena Rondón-Lagos
Journal:  Genes (Basel)       Date:  2017-06-03       Impact factor: 4.096

6.  The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells.

Authors:  Oorvashi Roy Puli; Brian P Danysh; Elena McBeath; Deepankar K Sinha; Nguyet M Hoang; Reid T Powell; Heather E Danysh; Maria E Cabanillas; Gilbert J Cote; Marie-Claude Hofmann
Journal:  Neoplasia       Date:  2018-09-25       Impact factor: 5.715

Review 7.  IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors.

Authors:  Mattias K Andersson; Pierre Åman; Göran Stenman
Journal:  Cells       Date:  2019-08-16       Impact factor: 6.600

8.  Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report.

Authors:  Kensuke Suzuki; Hiroshi Harada; Masayuki Takeda; Chisato Ohe; Yoshiko Uemura; Akihiko Kawahara; Shunsuke Sawada; Akira Kanda; Bhaswati Sengupta; Hiroshi Iwai
Journal:  BMC Med Genomics       Date:  2022-01-06       Impact factor: 3.063

Review 9.  Emerging Biomarkers in Thyroid Practice and Research.

Authors:  Shipra Agarwal; Andrey Bychkov; Chan-Kwon Jung
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 10.  NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision Medicine.

Authors:  Federica Zito Marino; Francesca Pagliuca; Andrea Ronchi; Immacolata Cozzolino; Marco Montella; Massimiliano Berretta; Maria Elena Errico; Vittoria Donofrio; Roberto Bianco; Renato Franco
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.